Life Sciences Transactions & Strategic Growth  | McDermott

McDermott Will & Schulte, a global law firm

Life Sciences Transactions

& Strategic Growth

Decorative graphic
Overview
The strategy behind your business growth

Pushing boundaries and moving forward, you’re always looking for what’s next. Be ready to take advantage of merger and acquisition opportunities with a hand-selected team of legal advisors by your side. We’ll navigate the complex and highly regulated life sciences landscape and help prevent challenges from holding you back. So you can keep moving at the pace of innovation.

It’s what we do: we fuel missions and knock down barriers to successfully negotiate and close deals on behalf of life sciences businesses large and small, worldwide.

See More

“[The firm] maintains a robust and comprehensive Life Sciences practice, calling on the world’s top 10 pharmaceutical companies and a host of medical device industry leaders.”

IAM Patent 1000

Blog

Health & Life Sciences News Blog

Exploring critical business and legal issues across the healthcare and life sciences industries

Visit

“McDermott Will & Schulte really knows how to work with clients to get the deal done. The team learns the industry and the business ramifications.”

– Client

Références
  • Siegfried Group on multiple transactions including the acquisition of significant parts of BASF’s pharmaceutical supply business and connected chemical-pharmaceutical production units and the acquisition of Hameln Pharmaceuticals and Hameln RDS, developers of sterile pharmaceutical products
  • Alliant Pharmaceuticals, Inc., with an approximately $100 million sale to Sciele Pharma, Inc.
  • Baird Capital Partners Asia and Frontage Laboratories in the acquisition of Advanced Biomedical Research, Inc., a clinical research company

See More

Insights
News
Interlocuteurs principaux
Additional capabilities

Droit de la Santé & des Sciences de la Vie

Private Equity